Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

類似資料

• Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
  著者:: Piekarska, Agnieszka, 等
  出版事項: (2015)
• Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation
  著者:: Sadowska-Klasa, Alicja, 等
  出版事項: (2017)
• Recurrent bowel-blood translocations of Escherichia coli with the unique virulence characteristics over three-year period in the patient with acute myeloid leukaemia – case report
  著者:: Krawczyk, Beata, 等
  出版事項: (2017)
• Successful treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disease with central nervous system involvement following allogeneic haematopoietic stem cell transplantation – a case study
  著者:: Wróblewska, Małgorzata, 等
  出版事項: (2015)
• Clinical Impact of Dose Reductions and Interruptions of Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukaemia
  著者:: Santos, Fabio P S, 等
  出版事項: (2010)